SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193805-20-001274
Filing Date
2020-10-15
Accepted
2020-10-15 06:27:00
Documents
12
Period of Report
2020-10-14
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 e6120001_8k-at.htm   iXBRL 8-K 22081
  Complete submission text file 0001193805-20-001274.txt   195028

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA arct-20201014.xsd EX-101.SCH 3192
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE arct-20201014_lab.xml EX-101.LAB 34591
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE arct-20201014_pre.xml EX-101.PRE 22714
5 EXTRACTED XBRL INSTANCE DOCUMENT e6120001_8k-at_htm.xml XML 3632
Mailing Address 10628 SCIENCE CENTER DRIVE SUITE 250 SAN DIEGO CA 92121
Business Address 10628 SCIENCE CENTER DRIVE SUITE 250 SAN DIEGO CA 92121 8589002660
Arcturus Therapeutics Holdings Inc. (Filer) CIK: 0001768224 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38942 | Film No.: 201240282
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences